Trial Results Search
Clinical Trial Results: NeoRecormon [epoetin beta]
-
Protocol Number: MA16620
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: ML18101
Product Name: NeoRecormon [epoetin beta]
Date of Report: 06.09.2006
Phase: IV
-
Protocol Number: ML18043
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.06.2009
Phase: IV
-
Protocol Number: ML18055
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Hematologic Malignancies.
-
Protocol Number: ML20201
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
-
Protocol Number: ML20828
Product Name: NeoRecormon [epoetin beta]
Date of Report: 23.02.2007
Phase: IV
A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
-
Protocol Number: ML18275
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon (Epoetin Beta) in Patients With Solid Tumors or Hematologic Malignancies
-
Protocol Number: ML20559
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: II
-
Protocol Number: ML20200
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon in Patients With Chronic Kidney Disease.
-
Protocol Number: ML17249
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: IV
A Study of NeoRecormon(Epoetin Beta)in Anemic Patients With Solid Tumors
-
Protocol Number: ML17777
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25362
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: IV
An Observational Study of NeoRecormon (Epoetin beta) in Anemic Patients With Non-myeloid Malignancy
-
Protocol Number: ML22733
Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: IV
An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)
-
Protocol Number: ML18028
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.03.2007
Phase: II
-
Protocol Number: ML17850
Product Name: NeoRecormon [epoetin beta]
Date of Report: 28.10.2005
Phase: II
-
Protocol Number: BH20198
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.08.2007
Phase: III
-
Protocol Number: ML18355
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.03.2007
Phase: IV
-
Protocol Number: ML17620
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.12.2006
Phase: III
-
Protocol Number: ML17616
Product Name: NeoRecormon [epoetin beta]
Date of Report: 18.12.2006
Phase: III
-
Protocol Number: ML18042
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.07.2006
Phase: IV
-
Protocol Number: ML18041
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.08.2006
Phase: IV
-
Protocol Number: BA16756
Product Name: NeoRecormon [epoetin beta]
Date of Report: 01.05.2006
Phase: III
-
Protocol Number: BA16169
Product Name: NeoRecormon [epoetin beta]
Date of Report: 02.05.2005
Phase: III
About This Database
This database is populated with information on the results of Roche-sponsored clinical trials.